Showing results (1661-1670 of 2,073) with videos related to

Sort By:
Pageof 208
Pediatric Diabetes|September 2, 2025
Corrigendum to "ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 Diabetes in Children and Adolescents"
Pediatric Diabetes|August 27, 2025
Prevalence and Risk Factors for Bladder and Bowel Dysfunction in Children With Type 1 DiabetesKristen Favel, Maryellen S Kelly, Shing Tat Theodore Lam, et al.
Pediatric Diabetes|August 7, 2021
Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for diabetes in youth studyRyan P Brady, Amy S Shah, Elizabeth T Jensen, et al.
Pediatric Diabetes|May 21, 2021
Evidence of a plateau in the incidence of type 1 diabetes in children 0-4 years of age from a regional pediatric diabetes center; Auckland, New Zealand: 1977-2019Samuel A Flint, Alistair J Gunn, Paul L Hofman, et al.
Pediatric Diabetes|May 21, 2021
Use of glucagon-like peptide-1 receptor agonists for pediatric patients with obesity and diabetes: The providers' perspectivesEvgenia Gourgari, Lina Huerta-Saenz, Ksenia N Tonyushkina, et al.
Pediatric Diabetes|August 9, 2021
Increasing plasma glucose before the development of type 1 diabetes-the TRIGR studyJohnny Ludvigsson, David Cuthbertson, Dorothy J Becker, et al.
Pediatric Diabetes|November 19, 2016
Diabetes conflict outstrips the positive impact of self-efficacy on youth adherence and glycemic control in type 1 diabetesAmy E Noser, Lindsay Huffhines, Mark A Clements, et al.
Pediatric Diabetes|October 12, 2016
Pathways to reduce diabetic ketoacidosis with new onset type 1 diabetes: Evidence from a regional pediatric diabetes center: Auckland, New Zealand, 2010 to 2014Eleanor R Gunn, Benjamin B Albert, Paul L Hofman, et al.
Pediatric Diabetes|November 4, 2016
Home-based vs inpatient education for children newly diagnosed with type 1 diabetesH Clapin, L Hop, E Ritchie, et al.
Pediatric Diabetes|November 4, 2016
Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimenV Sanoe Harrison, Stacy Rustico, Andrew A Palladino, et al.
Pageof 208